Clinical trial
Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study
NCT03084549 is registered in ClinicalTrials.gov with Centre Hospitalier Departemental Vendee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study
- Lead sponsor
- Centre Hospitalier Departemental Vendee
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 24, 2017
- Completion date
- November 4, 2020
- Enrollment
- 272 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
episiotomy